S'abonner

Early reduction of estimated Glomerular Filtration Rate (eGFR) predicts poor outcome in acutely ill hospitalized COVID-19 patients firstly admitted to medical regular wards (eGFR-COV19 study) - 31/08/22

Doi : 10.1016/j.biopha.2022.113454 
Francesco Cei a, , 1 , Ludia Chiarugi a, Simona Brancati a, Maria Silvia Montini a, Silvia Dolenti a, Daniele Di Stefano a, Salvatore Beatrice a, Irene Sellerio a, Valentina Messiniti a, Marco Maria Gucci a, Giulia Vannini a, Rinaldo Lavecchia a, Elisa Cioni b, Chiara Mattaliano b, Giulia Pelagalli b, Grazia Panigada c, Emanuele Murgo d, Gianluigi Mazzoccoli d, , 1 , Giancarlo Landini e, Roberto Tarquini a
a Division of Internal Medicine I, San Giuseppe Hospital, Empoli 50053, Italy 
b Division of Internal Medicine II, San Giuseppe Hospital, Empoli 50053, Italy 
c Division of Internal Medicine, SS. Cosma e Damiano Hospital, Pescia 51017, Italy 
d Division of Internal Medicine, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, FG, 71013, Italy 
e Division of Internal Medicine, Santa Maria Nuova Hospital, Firenze 50100, Italy 

Corresponding authors.

Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.

Connectez-vous pour en bénéficier!

Abstract

Background

Analysis of autopsy tissues obtained from patients who died from COVID-19 showed kidney tropism for SARS-COV-2, with COVID-19-related renal dysfunction representing an overlooked problem even in patients lacking previous history of chronic kidney disease. This study aimed to corroborate in a substantial sample of consecutive acutely ill COVID-19 hospitalized patients the efficacy of estimated GFR (eGFR), assessed at hospital admission, to identify acute renal function derangement and the predictive role of its association with in-hospital death and need for mechanical ventilation and admission to intensive care unit (ICU).

Methods

We retrospectively analyzed charts of 764 patients firstly admitted to regular medical wards (Division of Internal Medicine) for symptomatic COVID-19 between March 6th and May 30th, 2020 and between October 1st, 2020 and March 15th, 2021. eGFR values were calculated with the 2021 CKD-EPI formula and assessed at hospital admission and discharge. Baseline creatinine and GFR values were assessed by chart review of patients’ medical records from hospital admittance data in the previous year. The primary outcome was in-hospital mortality, while ARDS development and need for non-invasive ventilation (NIV) and invasive mechanical ventilation (IMV) were the secondary outcomes.

Results

SARS-COV-2 infection was diagnosed in 764 patients admitted with COVID-19 symptoms. A total of 682 patients (age range 23–100 years) were considered for statistical analysis, 310 needed mechanical ventilation and 137 died. An eGFR value <60 mL/min/1.73 m2 was found in 208 patients, 181 met KDIGO AKI criteria; eGFR values at hospital admission were significantly lower with respect to both hospital discharge and baseline values (p < 0.001). In multivariate analysis, an eGFR value <60 mL/min/1.73 m2 was significantly associated with in-hospital mortality (OR 2.6, 1.7–4.8, p = 0.003); no association was found with both ARDS and need for mechanical ventilation. eGFR was non-inferior to both IL-6 serum levels and CALL Score in predicting in-hospital death (AUC 0.71, 0.68–0.74, p = 0.55).

Conclusions

eGFR calculated at hospital admission correlated well with COVID-19-related kidney injury and eGFR values < 60 mL/min/1,73 m2 were independently associated with in-hospital mortality, but not with both ARDS or need for mechanical ventilation.

Le texte complet de cet article est disponible en PDF.

Graphical Abstract




ga1

Le texte complet de cet article est disponible en PDF.

Highlights

SARS-COV-2 infection causes kidney damage in several COVID-19 patients.
A biomarker to disclose SARS-COV-2-related developing renal dysfunction is lacking.
GFR estimated (eGFR) at hospital admission reveals emerging kidney injury in COVID-19.
eGFR at admission validates early prediction of COVID-19 patients in-hospital death.

Le texte complet de cet article est disponible en PDF.

Keywords : SARS-COV-2, COVID-19, Glomerular filtration rate, Acute kidney injury, Prognosis


Plan


© 2022  The Authors. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 153

Article 113454- septembre 2022 Retour au numéro
Article précédent Article précédent
  • Colchicine improves severe acute pancreatitis-induced acute lung injury by suppressing inflammation, apoptosis and oxidative stress in rats
  • Di Zhang, Lei Li, Jun Li, YunLei Wei, Jian Tang, Xiaohua Man, Feng Liu
| Article suivant Article suivant
  • The chemical constituents and gastroprotective effects of Calanthe fimbriata Franch
  • Chunping Yu, Yang Gao, Xin Wang, Rui Zhang, Nana Liu, Zhenji Rong, Zhigang Wang, Jing Yang, Miaoqin Xie, Hailong Zhang, He Bao

Bienvenue sur EM-consulte, la référence des professionnels de santé.

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.